Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

15.73

-0.36 (-2.24%)

At close: Mar 28, 2025, 4:00 PM

15.30

-0.44 (-2.77%)

Pre-market: Mar 31, 2025, 9:02 AM EDT

Arcutis Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2017
Operating Revenue	166.54	29.19	3.69	-	-	Upgrade
Other Revenue	30	30.42	-	-	-	Upgrade
Revenue	196.54	59.61	3.69	-	-	Upgrade
Revenue Growth (YoY)	229.73%	1517.09%	-	-	-	Upgrade
Cost of Revenue	19.13	4.99	0.75	-	-	Upgrade
Gross Profit	177.41	54.62	2.93	-	-	Upgrade
Selling, General & Admin	229.39	185.15	122.12	60.97	21.34	Upgrade
Research & Development	76.42	110.58	182.44	145.56	115.31	Upgrade
Operating Expenses	305.81	295.72	304.56	206.53	136.65	Upgrade
Operating Income	-128.4	-241.1	-301.63	-206.53	-136.65	Upgrade
Interest Expense	-27.17	-29.71	-15.65	-	-	Upgrade
Interest & Investment Income	16.17	11.79	5.82	0.17	0.97	Upgrade
Pretax Income	-139.39	-259.03	-311.46	-206.36	-135.68	Upgrade
Income Tax Expense	0.65	3.11	-	-	-	Upgrade
Net Income	-140.04	-262.14	-311.46	-206.36	-135.68	Upgrade
Net Income to Common	-140.04	-262.14	-311.46	-206.36	-135.68	Upgrade
Shares Outstanding (Basic)	121	69	55	49	36	Upgrade
Shares Outstanding (Diluted)	121	69	55	49	36	Upgrade
Shares Change (YoY)	74.53%	25.94%	11.39%	38.52%	1835.11%	Upgrade
EPS (Basic)	-1.16	-3.78	-5.66	-4.18	-3.80	Upgrade
EPS (Diluted)	-1.16	-3.78	-5.66	-4.18	-3.80	Upgrade
Free Cash Flow	-112.3	-247.49	-258.05	-175.62	-113.35	Upgrade
Free Cash Flow Per Share	-0.93	-3.57	-4.69	-3.56	-3.18	Upgrade
Gross Margin	90.27%	91.63%	79.54%	-	-	Upgrade
Operating Margin	-65.33%	-404.49%	-8183.04%	-	-	Upgrade
Profit Margin	-71.25%	-439.79%	-8449.76%	-	-	Upgrade
Free Cash Flow Margin	-57.14%	-415.20%	-7000.76%	-	-	Upgrade
EBITDA	-125.8	-239.58	-300.69	-206.08	-136.52	Upgrade
EBITDA Margin	-64.01%	-	-	-	-	Upgrade
D&A For EBITDA	2.6	1.52	0.93	0.45	0.12	Upgrade
EBIT	-128.4	-241.1	-301.63	-206.53	-136.65	Upgrade
EBIT Margin	-65.33%	-	-	-	-	Upgrade
Revenue as Reported	196.54	59.61	3.69	-	-	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q